Evidence map›Paper›PMID 38585551›Full record

ArticleMolecular syndromology2024

A Novel Variant in

Murat Erdogan, Suleyman Sunkak, Oguzhan Bahadır, Muhammet Ensar Doğan, Yasin Ada, Burhan Balta

Abstract read
In one paragraph

Article in Molecular syndromology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Murat ErdoganDepartment of Medical Genetics, Kayseri City Hospital, Kayseri, Turkey.
Suleyman SunkakDepartments of Pediatrics, Department of Pediatrics Cardiology, Kayseri City Hospital, Kayseri, Turkey.
Oguzhan BahadırDiagnoseq Laboratory, Ankara, Turkey.
Muhammet Ensar DoğanDepartment of Medical Genetics, Kayseri City Hospital, Kayseri, Turkey.
Yasin AdaDepartment of Medical Genetics, Kayseri City Hospital, Kayseri, Turkey.
Burhan BaltaDepartment of Medical Genetics, Kayseri City Hospital, Kayseri, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Long QT syndrome (LQTS) is a common congenital cause of fatal cardiac arrhythmia. Characteristic clinical findings are prolonged QT interval and ventricular arrhythmia on electrocardiogram (ECG), syncope, seizure, and sudden death. It is a genetically heterogeneous disease. To date, disease-causing variant have been reported in seventeen genes. The Case Report: We report the case of a 10-year-old female who was born from a non-consanguineous Turkish couple. She visited pediatrics cardiology clinic presenting with dyspnea and tachycardia. Prolongation of the QT interval was detected in her ECG. Panel test associated with LQTS genes was performed. She was diagnosed with long QTS type 11 due to a heterozygous variant in Discussion and Conclusion: Novel heterozygous frameshift variant in the

Indexed as

AKAP9 geneLong QT syndromeNext-generation sequencingNovel variantSilent carriers

Identifiers

PMID38585551
PMCPMC10996337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.